Works matching AU de Haas, Sanne


Results: 16
    1

    <sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

    Published in:
    Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
    By:
    • Oosting, Sjoukje F.;
    • Brouwers, Adrienne H.;
    • van Es, Suzanne C.;
    • Nagengast, Wouter B.;
    • Munnink, Thijs H. Oude;
    • Lub-de Hooge, Marjolijn N.;
    • Hollema, Harry;
    • de Jong, Johan R.;
    • de Jong, Igle J.;
    • de Haas, Sanne;
    • Scherer, Stefan J.;
    • Sluiter, Wim J.;
    • Dierckx, Rudi A.;
    • Bongaerts, Alfons H. H.;
    • Gietema, Jourik A.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    2
    3

    Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00477-z
    By:
    • Loibl, Sibylle;
    • Huang, Chiun-Sheng;
    • Mano, Max S.;
    • Mamounas, Eleftherios P.;
    • Geyer Jr, Charles E.;
    • Untch, Michael;
    • Thery, Jean-Christophe;
    • Schwaner, Ingo;
    • Limentani, Steven;
    • Loman, Niklas;
    • Lübbe, Kristina;
    • Chang, Jenny C.;
    • Hatschek, Thomas;
    • Tesarowski, David;
    • Song, Chunyan;
    • Lysbet de Haas, Sanne;
    • Boulet, Thomas;
    • Lambertini, Chiara;
    • Wolmark, Norman
    Publication type:
    Article
    4
    5
    6

    Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

    Published in:
    2019
    By:
    • Perez, Edith A.;
    • de Haas, Sanne Lysbet;
    • Eiermann, Wolfgang;
    • Barrios, Carlos H.;
    • Toi, Masakazu;
    • Im, Young-Hyuck;
    • Conte, Pier Franco;
    • Martin, Miguel;
    • Pienkowski, Tadeusz;
    • Pivot, Xavier B.;
    • Burris III, Howard A.;
    • Stanzel, Sven;
    • Patre, Monika;
    • Ellis, Paul Anthony;
    • Burris, Howard A 3rd
    Publication type:
    journal article
    7

    Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

    Published in:
    2019
    By:
    • Perez, Edith A.;
    • de Haas, Sanne Lysbet;
    • Eiermann, Wolfgang;
    • Barrios, Carlos H.;
    • Toi, Masakazu;
    • Im, Young-Hyuck;
    • Conte, Pier Franco;
    • Martin, Miguel;
    • Pienkowski, Tadeusz;
    • Pivot, Xavier B.;
    • Burris III, Howard A.;
    • Stanzel, Sven;
    • Patre, Monika;
    • Ellis, Paul Anthony;
    • Burris, Howard A 3rd
    Publication type:
    journal article
    8
    9

    Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.

    Published in:
    2019
    By:
    • Perez, Edith A.;
    • Barrios, Carlos;
    • Eiermann, Wolfgang;
    • Toi, Masakazu;
    • Im, Young‐Hyuck;
    • Conte, Pierfranco;
    • Martin, Miguel;
    • Pienkowski, Tadeusz;
    • Pivot, Xavier B.;
    • Burris, Howard A.;
    • Petersen, Jennifer A.;
    • De Haas, Sanne;
    • Hoersch, Silke;
    • Patre, Monika;
    • Ellis, Paul Anthony;
    • Im, Young-Hyuck;
    • Burris, Howard A 3rd
    Publication type:
    journal article
    10
    11

    BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.

    Published in:
    Cancers, 2022, v. 14, n. 11, p. 2596, doi. 10.3390/cancers14112596
    By:
    • Dang, Chau;
    • Ewer, Michael S.;
    • Delaloge, Suzette;
    • Ferrero, Jean-Marc;
    • Colomer, Ramon;
    • de la Cruz-Merino, Luis;
    • Werner, Theresa L.;
    • Dadswell, Katherine;
    • Verrill, Mark;
    • Eiger, Daniel;
    • Sarkar, Sriparna;
    • de Haas, Sanne Lysbet;
    • Restuccia, Eleonora;
    • Swain, Sandra M.
    Publication type:
    Article
    12

    Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer.

    Published in:
    Cancers, 2021, v. 13, n. 19, p. 4884, doi. 10.3390/cancers13194884
    By:
    • Harbeck, Nadia;
    • von Schumann, Raquel;
    • Kates, Ronald Ernest;
    • Braun, Michael;
    • Kuemmel, Sherko;
    • Schumacher, Claudia;
    • Potenberg, Jochem;
    • Malter, Wolfram;
    • Augustin, Doris;
    • Aktas, Bahriye;
    • Forstbauer, Helmut;
    • Tio, Joke;
    • Grischke, Eva-Maria;
    • Biehl, Claudia;
    • Liedtke, Cornelia;
    • De Haas, Sanne Lysbet;
    • Deurloo, Regula;
    • Wuerstlein, Rachel;
    • Kreipe, Hans Heinrich;
    • Gluz, Oleg
    Publication type:
    Article
    13

    Promotion of sleep by targeting the orexin system in rats, dogs and humans.

    Published in:
    Nature Medicine, 2007, v. 13, n. 2, p. 150, doi. 10.1038/nm1544
    By:
    • Brisbare-Roch, Catherine;
    • Dingemanse, Jasper;
    • Koberstein, Ralf;
    • Hoever, Petra;
    • Aissaoui, Hamed;
    • Flores, Susan;
    • Mueller, Celia;
    • Nayler, Oliver;
    • van Gerven, Joop;
    • de Haas, Sanne L;
    • Hess, Patrick;
    • Qiu, Changbin;
    • Buchmann, Stephan;
    • Scherz, Michael;
    • Weller, Thomas;
    • Fischli, Walter;
    • Clozel, Martine;
    • Jenck, François
    Publication type:
    Article
    14
    15
    16